Marc Rodger profile picture

Contact Information

Marc Rodger
613 737 8899 ext 74641

ORCID logo


Active Grants

2017-2022 Apixaban Twice Daily vs Rivaroxaban Once Daily for the Treatment of Venous Thromboembolism: A Randomized controlled trial - CIHR PJT 153267, Role: Co-Principal Investigator

2016-2019 Statins for Venous Event Reduction in patients with venous thromboembolism (The SAVER Pilot Randomized Trial) - CIHR 365588 - Role: Principal Applicant

2016-2019 Safely Ruling out Deep Vein Thrombosis in Pregnancy with the LEFt Clinical Decision Rule and D-dimer (the LEaD study): A Prospective Cohort Study - CIHR 364517 - Role: Principal Applicant

2015-2020 ICRH Community Development Program Grants - Sleep and Circadian Rhythms and Venous Thromboembolism Diseases Clinical Trials Grant CIHR CDT 142654 - Role: Co-Principal Applicant

2015-2022 Improving long term outcomes with venous thromboembolism (VTE)
CIHR Foundation Grant - Role: Program Expert

2015-2018 Age-adjusted D-dimer cut-off levels to rule out deep vein thrombosis (The ADJUST-DVT Study)
HSFC G-15-0009003 - Role: Co-Investigator